27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Shares of Sorrento Therapeutics Inc (NASDAQ:SRNE) traded 13.5% lower in after-hours trading on Tuesday as a reaction to the company firing its Chief Financial Officer Jiong Shao.
What Happened: Sorrento Therapeutics, a biotech drug manufacturer in a filing with the Securities and Exchange Commission stated that Shao is "terminated in its entirety, effectively immediately." Further, the company announced it has appointed Najjam Asghar as its new CFO.
Asghar has already been performing the role of chief accounting officer for the company since June 2019.
Why It Matters: Shao’s termination comes as the company deals with short seller Hindenburg Research.
In May, Sorrento rolled with its news of high potential and rapid COVID-19 Slyvia testing, which led the stock to be up 263% year to date. The conflict with short sellers over allegations of potential manipulation had created questions on the credibility of the company and its testing process.
Price Action: Shares of Sorrento Therapeutics gained 1.5% on Tuesday to close trading at $12.28 before losing over 13% in after-hours trading.
Editor's note: A previous version of this article incorrectly implied Shao was associated with Hindenburg Research.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!